Merck reaches $830M settlement in long-running Vioxx litigation

Emily Wasserman

is closing a chapter in its seemingly never-ending saga for its painkiller , agreeing to pay more than $ 800 million to settle a lawsuit over the med years after the company pulled its product from the market and shelled out billions to resolve additional suits.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS